MINNESOTA CLINICAL STUDY CENTER

Advancing medical treatment for skin diseases takes teamwork.  Our team is dedicated to your care as a research participant.  All studies are fully voluntary and comply with strict privacy and ethical standards. Dr. Steven Kempers is a Board certified Dermatologist with over 27 years of clinical trial experience.  If you are interested in one of our active studies, sign up today or leave a message on our Study Line (763) 502-2941. We are open Monday through Thursday, 7:30am to 4:30pm.

The Minnesota Clinical Study Center (MCSC) is an independent, privately owned clinical trial research center devoted to conducting clinical trials for diseases of the skin and cosmetic procedures. We are continually starting new and exciting trials that offer new treatments and promising drugs long before they are available to the public. Please check back often.

Clinical Trial Information

What is a Clinical Trial?

Clinical Trial

Clinical research trials are used to test and evaluate investigational drugs and treatments. Before a new investigational drug or treatment can be considered for approval by the U.S. Food and Drug Administration (FDA), it must be shown to be both safe and effective. A carefully monitored clinical research trial is the best way to find out if a new treatment is safe, effective, or better than medications that are already available.

Phase I trials are the first step in testing a new drug on people. These are small studies where everybody in the study is given the same drug. Phase I trials answer questions about the best way to give the drug and how much of it can be given safely. The study staff watches carefully for harmful side effects and other possible risks.

Phase II trials are larger studies that continue to test the safety of the new drug. Phase II trials also begin to test how well the new drug works by comparing the new test drug with a standard treatment. In some cases, such as when there is no effective treatment for a condition, the new drug is compared to a placebo, that is, a treatment with no active ingredient.

Phase III trials are very large studies that are conducted nationally and/or internationally if the new drug showed promise in Phase II studies. Phase III trials compare a new drug with the standard treatment to see which one is more effective. In some cases the new drug is compared to a placebo. Side effects are also studied. Phase III trials are usually randomized. Randomization is a research method that helps prevent the results of a clinical trial from being biased. Participants agree to be randomly selected, that is, assigned by chance, to one group or another in the research study.

Phase IV trials may be done after the new drug or treatment is already approved for use by the Food and Drug Administration. These studies continue to test the effects of the drug on different types of people, and to look for long-term side effects.

Who Can Participate in a Clinical Trial?
Sponsor Information
What Trials Are Currently Going On?

Interested in participating in a clinical trial? Fill out this form!

research-page-5-214x300
IMG_2592

Our Staff

PRINCIPAL INVESTIGATOR: STEVEN E. KEMPERS, MD

Steven E Kempers

MD, FAAD

 

Steven E Kempers
MD, FAAD

Bio:
Undergraduate Education:
Ohio Wesleyan University, Delaware, Ohio

Medical Education:
University of Pennsylvania, Philadelphia, Pennsylvania

Post Graduate Training and Fellowships:
Internship, Santa Barbara Cottage Hospital, Santa Barbara, California
Dermatology Residency, University of Minnesota, Minneapolis, Minnesota

Certifications and Accreditations:
American Board of Dermatology

Academic Appointments:
Adjunct Associate Professor, University of Minnesota, Department of Dermatology

Specialty:
General Dermatology
Research Dermatology

Location:
University Avenue Clinic

Close
SUB-INVESTIGATOR: ROGER WEENIG, MD

Roger H Weenig

MD, MPH, FAAD, FASDP

 

Roger H Weenig
MD, MPH, FAAD, FASDP

Bio:
Undergraduate Education:
University of Utah

Master of Public Health Degree
University of Utah

Medical Education:
Temple University School of Medicine

Post Graduate Training & Fellowships:
Dermatology Residency, Mayo Clinic, Rochester, MN
Dermatopathology Fellowship, Mayo Clinic, Rochester, MN

Internship, Mayo Clinic, Jacksonville, FL

Certifications & Accreditations:
Special Qualification in Dermatopathology
American Board of Dermatology
American Board of Pathology

Academic Appointment:
Adjunct Assistant Professor at the University of Minnesota, Dept. Of Dermatology

Specialty:
General Dermatology
Dermatopathology

Location:
University Avenue Clinic

Close
SUB-INVESTIGATOR: JANE LINDHOLM, MD

Jane S Lindholm

MD, FAAD, FASDP

 

Jane S Lindholm
MD, FAAD, FASDP

Bio:
Undergraduate Education:
University of Iowa, Iowa City, Iowa

Medical Education:
University of Iowa, Iowa City, Iowa

Post Graduate Training and Fellowships:
Dermatology Residency, University of Iowa
Dermatopathology Fellowship, University of Cincinnati

Certifications and Accreditations:
Special Qualification in Dermatopathology
American Board of Dermatology
American Board of Pathology

Academic Appointments:
Adjunct Professor, University of Minnesota

Specialty:
Dermatopathology

Location:
University Avenue Clinic

Close
RESEARCH SUPERVISOR: DAWN SNOW, LPN, CCRC
RECRUITER/ RECEPTIONIST: ALLISON HORITA
COORDINATOR: DONNA ROBERTS, RN, CCRC
COORDINATOR: CHERE DOERSCHER, LPN, CCRC
COORDINATOR: BARBARA SCHWANDT, CCRC
COORDINATOR: ALISSA PROCHNIAK, MA, CCRC
COORDINATOR: SOBELLA NIETO, CMA, CCRC
RESEARCH ASSISTANT: KARI HEIMER, CMA

Contact Us

Phone Number: 763-571-4200

Study Line: 763-502-2941

MCSC